3 Must-Buy Stocks for June 24, 2025 – Top Analysts’ Highest-Conviction Picks

Markets roar as analysts drop their hottest equity plays—just in time for summer portfolio rotations.

Wall Street’s Whisper List

Forget the dartboard picks. These three stocks boast buy ratings from analysts who actually read 10-K filings (occasionally).

Liquidity Over Lore

No ‘story stocks’ here—just names with institutional backing thick enough to survive the next Fed pivot tantrum.

Bonus Reality Check

Remember: ‘Top analyst’ usually means ‘employed by a bank that underwrote the stock.’ But hey—free alpha tastes better when it’s conflicted.

Confident Investing Starts Here:

• Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
• Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter

To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts. 

Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio.

(LLY) – Eli Lilly is a U.S.-based pharmaceutical company focused on developing and marketing medicines for conditions like diabetes, cancer, and neurological disorders. Yesterday, BMO Capital analyst Evan Seigerman maintained a Buy rating on the stock with a price target of $900 per share. Interestingly, nine out of the 10 Top Analysts who recently rated the stock gave it a Buy. Taken together, their 12-month price targets imply an upside of about 26.42%. 

(SLDB) – This is a genetic medicine biotech company focused on developing precision gene therapies for rare neuromuscular and cardiac diseases. Yesterday, Truist Financial analyst Joon Lee maintained a Buy rating on the stock. In the last three months, all six Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 284%.

(MRVL) – Marvell is a fabless semiconductor company that specializes in data-center, networking, storage, and custom AI chips. Yesterday, Craig-Hallum analyst Christian Schwab maintained a Buy rating on the stock. Interestingly, 24 out of the 26 Top Analysts who recently rated the stock gave it a Buy. Taken together, their 12-month price targets imply an upside of about 31.6%. 

Who Are the Top Analysts? 

TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. The Top Analysts have each earned a five-star ranking, thanks to the accuracy and profitability of their ratings over time. 

See real-time analyst rankings and learn more about the performance of Top Analysts on TipRanks’ Top Wall Street Analysts page. 

Disclosure